Background For patients with early American Joint Committee on Cancer (AJCC)-stage melanoma the combined loss of the autophagy regulatory protein AMBRA1 and the terminal differentiation marker loricrin in the peritumoral epidermis is associated with a significantly increased risk of metastasis. Objectives The aim of the present study was to evaluate the potential contribution of melanoma paracrine transforming growth factor (TGF)-beta signalling to the loss of AMBRA1 in the epidermis overlying the primary tumour and disruption of epidermal integrity. Methods Immunohistochemistry was used to analyse AMBRA1 and TGF-beta 2 in a cohort of 109 AJCC all-stage melanomas, and TGF-beta 2 and claudin-1 in a cohort of 30 or 42 AJCC stage I melanomas, respectively, with known AMBRA1 and loricrin (AMLo) expression. Evidence of pre-ulceration was analysed in a cohort of 42 melanomas, with TGF-beta 2 signalling evaluated in primary keratinocytes. Results Increased tumoral TGF-beta 2 was significantly associated with loss of peritumoral AMBRA1 (P < 0 center dot 05), ulceration (P < 0 center dot 001), AMLo high-risk status (P < 0 center dot 05) and metastasis (P < 0 center dot 01). TGF-beta 2 treatment of keratinocytes resulted in downregulation of AMBRA1, loricrin and claudin-1, while knockdown of AMBRA1 was associated with decreased expression of claudin-1 and increased proliferation of keratinocytes (P < 0 center dot 05). Importantly, we show loss of AMBRA1 in the peritumoral epidermis was associated with decreased claudin-1 expression (P < 0 center dot 05), parakeratosis (P < 0 center dot 01) and cleft formation in the dermoepidermal junction (P < 0 center dot 05). Conclusions Collectively, these data suggest a paracrine mechanism whereby TGF-beta 2 causes loss of AMBRA1 overlying high-risk AJCC early-stage melanomas and reduced epidermal integrity, thereby facilitating erosion of the epidermis and tumour ulceration.

Cosgarea, I., Mcconnell, A.t., Ewen, T., Tang, D., Hill, D.s., Anagnostou, M., et al. (2022). Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration*. BRITISH JOURNAL OF DERMATOLOGY, 186(4), 694-704 [10.1111/bjd.20889].

Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration*

Giglio P.;Gagliardi M.;Piacentini M.;Corazzari M.;
2022-01-01

Abstract

Background For patients with early American Joint Committee on Cancer (AJCC)-stage melanoma the combined loss of the autophagy regulatory protein AMBRA1 and the terminal differentiation marker loricrin in the peritumoral epidermis is associated with a significantly increased risk of metastasis. Objectives The aim of the present study was to evaluate the potential contribution of melanoma paracrine transforming growth factor (TGF)-beta signalling to the loss of AMBRA1 in the epidermis overlying the primary tumour and disruption of epidermal integrity. Methods Immunohistochemistry was used to analyse AMBRA1 and TGF-beta 2 in a cohort of 109 AJCC all-stage melanomas, and TGF-beta 2 and claudin-1 in a cohort of 30 or 42 AJCC stage I melanomas, respectively, with known AMBRA1 and loricrin (AMLo) expression. Evidence of pre-ulceration was analysed in a cohort of 42 melanomas, with TGF-beta 2 signalling evaluated in primary keratinocytes. Results Increased tumoral TGF-beta 2 was significantly associated with loss of peritumoral AMBRA1 (P < 0 center dot 05), ulceration (P < 0 center dot 001), AMLo high-risk status (P < 0 center dot 05) and metastasis (P < 0 center dot 01). TGF-beta 2 treatment of keratinocytes resulted in downregulation of AMBRA1, loricrin and claudin-1, while knockdown of AMBRA1 was associated with decreased expression of claudin-1 and increased proliferation of keratinocytes (P < 0 center dot 05). Importantly, we show loss of AMBRA1 in the peritumoral epidermis was associated with decreased claudin-1 expression (P < 0 center dot 05), parakeratosis (P < 0 center dot 01) and cleft formation in the dermoepidermal junction (P < 0 center dot 05). Conclusions Collectively, these data suggest a paracrine mechanism whereby TGF-beta 2 causes loss of AMBRA1 overlying high-risk AJCC early-stage melanomas and reduced epidermal integrity, thereby facilitating erosion of the epidermis and tumour ulceration.
2022
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore BIO/06 - ANATOMIA COMPARATA E CITOLOGIA
English
Con Impact Factor ISI
Cosgarea, I., Mcconnell, A.t., Ewen, T., Tang, D., Hill, D.s., Anagnostou, M., et al. (2022). Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration*. BRITISH JOURNAL OF DERMATOLOGY, 186(4), 694-704 [10.1111/bjd.20889].
Cosgarea, I; Mcconnell, At; Ewen, T; Tang, D; Hill, Ds; Anagnostou, M; Elias, M; Ellis, Ra; Murray, A; Spender, Lc; Giglio, P; Gagliardi, M; Greenwood, A; Piacentini, M; Inman, Gj; Fimia, Gm; Corazzari, M; Armstrong, Jl; Lovat, Pe
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/331627
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact